Min Liu

Min Liu

Auto-generated profile, based on publicly available information

Min Liu

The First Affiliated Hospital Guangzhou University of Chinese Medicine Guangzhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2023 in European Journal of Pharmacology
Verified
Journal Article
Closed access
CLChuting Li
Chuting Li
XZXuting Zhang
Xuting Zhang
JLJie Li
Jie Li
LLLiyin Liang
Liyin Liang
JZJingran Zeng
Jingran Zeng
HHHeqing Huang
Heqing Huang

10 December 2020 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
DXDongfang Xiang
Dongfang Xiang
MZMin Zhao
Min Zhao
XCXiaofan Cai
Xiaofan Cai
YWYongxia Wang
Yongxia Wang
LZLei Zhang
Lei Zhang
PYPAUL YAO
PAUL YAO
Endometriosis is an inflammatory gynecological disorder characterized by endometrial tissue growth located outside of the uterine cavity in addition to chronic pelvic pain and infertility. In this study, we aim to develop a potential therapeutic treatment based on the pathogenesis and mechanism of Endometriosis. Our preliminary data showed that the expression of estrogen receptor β (ERβ) was significantly increased, while ERα was significantly decreased, in endometriotic cells compared to normal endometrial cells. Further investigation showed that betulinic acid (BA) treatment suppressed ERβ expression through epigenetic modification on the ERβ promoter, while had no effect on ERα expression. In addition, BA treatment suppresses ERβ target genes, including superoxide dismutase 2 (SOD2), nuclear respiratory factor-1 (NRF1), cyclooxygenase 2 (COX2), and matrix metalloproteinase-1 (MMP1), subsequently increasing oxidative stress, triggering mitochondrial dysfunction, decreasing elevated proinflammatory cytokines, and eventually suppressing endometriotic cell proliferation, mimicking the effect of ERβ knockdown. On the other hand, gain of ERβ by lentivirus infection in normal endometrial cells resulted in increased cell proliferation and proinflammatory cytokine release, while BA treatment diminished this effect through ERβ suppression with subsequent oxidative stress and apoptosis. Our results indicate that ERβ may be a major driving force for the development of endometriosis, while BA inhibits Endometriosis through specific suppression of the ERβ signaling pathway. This study provides a novel therapeutic strategy for endometriosis treatment through BA-mediated ERβ suppression.


17 July 2023 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JZJingran Zeng
Jingran Zeng
LLLiyin Liang
Liyin Liang
RCRui Chen
Rui Chen
CLChuting Li
Chuting Li
LPLinjie Pan
Linjie Pan
HHHeqing Huang
Heqing Huang

2 April 2024 in Materials Technology
Verified
Journal Article
Open access
LZLicui Zhang
Licui Zhang
CZChen Zhong
Chen Zhong
QYQi Yang
Qi Yang
MLMin Liu
Min Liu

28 March 2021 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
TLTong Lin
Tong Lin
FHFan Huang
Fan Huang
SZSiyi Zhao
Siyi Zhao
MQMingwang Qiu
Mingwang Qiu
JWJunmao Wen
Junmao Wen
MLMin Liu
Min Liu